feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Doctor's 'Eureka!' Moment Saves Patient's Life

Doctor's 'Eureka!' Moment Saves Patient's Life

11 Jan

•

Summary

  • Young man faced life-threatening illness with unknown cause.
  • Resident physician identified rare TAFRO syndrome after extensive research.
  • New diagnostic method speeds up rare disease identification significantly.

A young graduate faced a sudden, severe illness in the summer of 2023, experiencing rapid weight gain and organ distress. Despite extensive hospital testing, the cause remained elusive, leaving his family and medical team desperate. His condition worsened critically, with doctors fearing he might not survive the night.

A first-year resident, Dr. Steven Rowe, dedicated extra hours to research, poring over medical literature. His persistence led to a breakthrough when he identified a rare subtype of Castleman disease, TAFRO syndrome, which perfectly matched the patient's symptoms. This pivotal discovery occurred around 11 p.m. one night, prompting an immediate alert to the medical team.

Formal diagnosis confirmed TAFRO syndrome, a rare condition with a high mortality rate if untreated. The patient responded well to a new treatment, siltuximab, and was discharged in time for Christmas. This case spurred further research, resulting in a new diagnostic approach that can distinguish TAFRO syndrome from similar conditions with near 99% accuracy, drastically reducing diagnosis time.

trending

Roblox CEO sells stock

trending

Tigers linked to Bassitt, Giolito

trending

Wawrinka gets Australian Open wildcard

trending

Ozark Trail stoves recalled

trending

Switzerland reaches United Cup final

trending

Hurkacz leads Poland to title

trending

Medvedev credits Aussie coach revival

trending

Adithya Ashok: New Zealand Squad

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Dr. Steven Rowe diagnosed a rare subtype of Castleman disease called TAFRO syndrome in Ian Gillies Jr.
Ian Gillies Jr. was saved by a new treatment called siltuximab, administered intravenously, after the correct diagnosis of TAFRO syndrome was made.
The new study developed a simple blood test that can distinguish TAFRO syndrome from HLH with high accuracy, speeding up diagnosis.

Read more news on

Healthside-arrow

You may also like

Beyond Lifestyle: Unveiling Genetic Cancer

9 Jan • 16 reads

article image

Mom's Gut Feeling Saves Toddler From Rare Illness

6 Jan • 32 reads

article image

Teen's Christmas Album Aids Chronic Fatigue Battle

21 Dec, 2025 • 109 reads

article image

Teen denied 'miracle drug' in postcode lottery

10 Dec, 2025 • 180 reads

article image

Mom's Instinct: Early Signs of Rare Brain Disorder

4 Dec, 2025 • 180 reads

article image